NANOTROL Trademark

Trademark Overview


On Friday, June 13, 2025, a trademark application was filed for NANOTROL with the United States Patent and Trademark Office. The USPTO has given the NANOTROL trademark a serial number of 99232403. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 13, 2025. The NANOTROL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of Oral, IV, Opthalmic, Topical formulation of nanosalsalate Rheumatoid arthritis Osteoarthritis Gout vasculitis Fibromyalgia Inflammatory bowel disease (IBD) Chronic fatigue syndrome Traumatic brain injury (TBI) Chronic traumatic encephalopathy (CTE) Progressive supranuclear palsy (PSP) Non-Alzheimer’s tauopathies Alzheimer's disease Cytokine Storm & Immune Overactivation Cytokine release syndrome (CRS) Graft-versus-host disease (GvHD) Acute respiratory dis

Scientific study and research in the field(s) of Development services in the field of novel nano-based drug delivery systems
nanotrol

General Information


Serial Number99232403
Word MarkNANOTROL
Filing DateFriday, June 13, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, June 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of Oral, IV, Opthalmic, Topical formulation of nanosalsalate Rheumatoid arthritis Osteoarthritis Gout vasculitis Fibromyalgia Inflammatory bowel disease (IBD) Chronic fatigue syndrome Traumatic brain injury (TBI) Chronic traumatic encephalopathy (CTE) Progressive supranuclear palsy (PSP) Non-Alzheimer’s tauopathies Alzheimer's disease Cytokine Storm & Immune Overactivation Cytokine release syndrome (CRS) Graft-versus-host disease (GvHD) Acute respiratory dis
NOT AVAILABLENo claim is made to the exclusive right to use NANOTROL, apart from the mark as shown.
Goods and ServicesScientific study and research in the field(s) of Development services in the field of novel nano-based drug delivery systems

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 13, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 13, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
Addressprinceton, NJ 08540

Trademark Events


Event DateEvent Description
Friday, June 13, 2025NEW APPLICATION ENTERED
Friday, June 13, 2025APPLICATION FILING RECEIPT MAILED